Concepedia

Davis Y. Torrejon

DY

Statistics

Publications

18

Citations

8.5K

H-Index

17

Active since

2011

Affiliations

University of California, Los Angeles(Current)

Parker Institute for Cancer Immunotherapy

Vall d'Hebron Hospital Universitari

UCLA Jonsson Comprehensive Cancer Center

Universitat Autònoma de Barcelona

Davis Y. Torrejon is an author at University of California, Los Angeles specializing in medicine, pathology, and tumor biology.

ORCID

Top concepts

Publications per year

2011–2023

18

Publications

18

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma

Jesse M. Zaretsky, Ángel García-Díaz, Daniel Sanghoon Shin et al. · New England Journal of Medicine · 2016 · 3.1K citations · Full text

Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression

Ángel García-Díaz, Daniel Sanghoon Shin, Blanca Homet Moreno et al. · Cell Reports · 2017 · 1.8K citations · Full text

Primary Resistance to PD-1 Blockade Mediated by <i>JAK1/2</i> Mutations

Daniel Sanghoon Shin, Jesse M. Zaretsky, Helena Escuin-Ordinas et al. · Cancer Discovery · 2016 · 1.2K citations · Full text

Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma

Leticia De Mattos‐Arruda, Regina Mayor, Charlotte K.Y. Ng et al. · Nature Communications · 2015 · 822 citations · Full text

, , +19

Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma

Catherine S. Grasso, Jennifer Tsoi, Mykola Onyshchenko et al. · Cancer Cell · 2020 · 361 citations · Full text

, , +7

1–5 of 18